Fund recommendations to play 3 themes that make for timely investments today and yet don’t bring the high valuation risk that comes with overheated themes.
Prime Picks: 3 thematic funds for tomorrow’s markets Read More »
There are five new fund additions across equity, debt and hybrid in this quarter’s review.
Quarterly review – Changes to Prime Funds & Prime ETFs Read More »
If you thought you could by-pass mutual funds and dive straight into stock investing, this article will tell you why you still need a MF portfolio.
Why stock investors need a MF portfolio Read More »
We’ve kept changes to a minimum in this quarterly review. Find out more in this detailed report.
Quarterly Review – Changes to Prime Funds & Prime ETFs Read More »
Our recent call has been in the limelight. Here is a short note about such calls.
A short note about our recent call Read More »
What is front running and how does this news impact your investments – Find out here!
Front-running of Quant AMC – what you should do with your Quant funds Read More »
‘Opportunities’ funds pick sectors and stocks that are in special situations or are turning around or can benefit from a change in regulation etc. Two of these funds figure in Prime Funds. Find out why in this report.
Prime Fund Recommendation – Two ‘Opportunities’ funds to add to your portfolio Read More »
Learn all about the new fund category we added to Prime Funds – ‘Equity – high-risk turnarounds’, and the funds that belong to this category.
Prime Funds: 3 high-risk funds recently added Read More »
In this quarterly review, we have added a new set in equity Prime Funds, and have made a few other changes in recommendations.
Quarterly review – Changes to Prime Funds & Prime ETFs Read More »
All your questions on reviewing your MF portfolio, covering frequency, spotting under-performers and dealing with them, answered here.
How to review your mutual fund portfolio Read More »
With the Sensex zooming past 70k, if you are wondering whether to book profits, then you should read this.
How to book profits in your mutual fund portfolio Read More »
Taking a loan against mutual fund investments without breaking them can seem like an attractive option to tide over a temporary cash crunch. Aarati Krishnan evaluates the merits of this financing arrangement.
Should you go for loan against mutual funds? Read More »
The purpose of these disclosures is to provide essential information about the Research Services in a manner to assist and enable the prospective client/client in making an informed decision for engaging in Research services before onboarding. History, Present business and Background: PrimeInvestor Financial Research Private Limited is registered with SEBI as Research Analyst with registration no. INH200008653. The Research Analyst got its registration on August 19, 2021 and is engaged in offering research and recommendation services. Terms and conditions of Research Services: The Research Services will be limited to providing independent research recommendation and shall not be involved in any advisory or portfolio allocation services. The Research Analyst never guarantees the returns on the recommendation provided. Investor shall take note that Investment/trading in stocks/Index or other securities is always subject to market risk. Past performance is never a guarantee of same future results. The Research Analyst shall not be responsible for any loss to the Investors. Disciplinary history: There are no pending material litigations or legal proceedings against the Research Analyst. As on date, no penalties / directions have been issued by SEBI under the SEBI Act or Regulations made there under against the Research Analyst relating to Research Analyst services. Details of its associates: No associates. Disclosures with respect to Research and Recommendations Services: The Research Analyst or its directors or any of its officer/employee does not trade in securities which are subject matter of recommendation. There are no actual or potential conflicts of interest arising from any connection to or association with any issuer of products/ securities, including any material information or facts that might compromise its objectivity or independence in the carrying on of Research Analyst services. Such conflict of interest shall be disclosed to the client as and when they arise. Research Analyst or its directors or its employee or its associates have not received any compensation from the company which is subject matter of recommendation. Research Analyst or its directors or its employee or its associates have not managed or co-managed the public offering of any company. Research Analyst or its directors or its employee or its associates have not received any compensation for investment banking or merchant banking of brokerage services from the subject company. Research Analyst or its directors or its employee or its associates have not received any compensation for products or services other than above from the subject company. Research Analyst or its directors or its employee or its associates have not received any compensation or other benefits from the Subject Company or 3rd party in connection with the research report/ recommendation. The subject company was not a client of Research Analyst or its directors or its employee or its associates during twelve months preceding the date of recommendation services provided. Research Analysts or its directors or its employee or its associates has not served as an officer, director or employee of the subject company. Research Analysts has not been engaged in market making activity of the subject company.
Full disclosures and disclaimers
Compliance Officer Details: Name: Srikanth Meenakshi; Email: contact@primeinvestor.
Grievance Officer Details: Name: Srikanth Meenakshi; Email: contact@primeinvestor.
